Lupin receives approval from U.S. FDA for Fluocinolone Acetonide Topical Oil

Global pharma major Lupin Limited (Lupin) has announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil), a generic equivalent of Derma-Smoothe/FS® Topical Oil, 0.01% (Scalp Oil), of Hill Dermaceuticals, Inc. This product will be manufactured at Lupin's Somerset facility in the US.

Fluocinolone Acetonide Topical Oil (RLD Derma-Smoothe/FS®) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT Mar 2023).

Shares of Lupin Limited was last trading in BSE at Rs. 993.90 as compared to the previous close of Rs. 988.25. The total number of shares traded during the day was 59380 in over 3977 trades.

The stock hit an intraday high of Rs. 998.65 and intraday low of 974.50. The net turnover during the day was Rs. 58505713.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 NovelLaboratories USFDA Approval ANDA FluocinoloneAcetonideTopicalOil ScalpOil